Despite Shenyang Xingqi Pharmaceutical Ltd's weak recent rev...
Despite Shenyang Xingqi Pharmaceutical Ltd's weak recent revenue performance, the high P/S ratio points to investors holding stocks, anticipating significant revenue recovery. But with forecasted growth mirrored by the industry, the current ratio may not be sustainable without improved performance.
Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) Shares May Have Run Too Fast Too Soon
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment